Brief: Shield Therapeutics PLC Says Guidance Remains On Track To Turn Cash Flow Positive By End Of 2025
03/09/2025 14:47
Sept 3 (Reuters) - Shield Therapeutics PLC STXS.L: SHIELD THERAPEUTICS PLC: GUIDANCE REMAINS ON TRACK TO TURN CASH FLOW POSITIVE BY END OF 2025 Source text: ID:nRSU2993Wa Further company coverage: STXS.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update